A Phase 3, Multicenter, Open Label, Randomized, Non-Comparative Two-Arm Study of Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Adult Patients with Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) with an Isocitrate…

Full Title

A Phase 3, Multicenter, Open Label, Randomized, Non-Comparative Two-Arm Study of Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Adult Patients with Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) with an Isocitrate Dehydrogenase-1 (IDH1) Mutation (PyramIDH study) (Advarra IRB)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Tamanna Haque’s office at 646-608-4166.